Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:50-55
Published online before print November 30, 2006, doi: 10.1161/01.STR.0000251719.59141.36
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/1/50    most recent
01.STR.0000251719.59141.36v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oksala, N. K.J.
Right arrow Articles by Karhunen, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oksala, N. K.J.
Right arrow Articles by Karhunen, P. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Medline Plus Health Information
*Smoking
Related Collections
Right arrow Aggregation
Right arrow Genetics of Stroke
Right arrow Risk Factors for Stroke

(Stroke. 2007;38:50.)
© 2007 American Heart Association, Inc.


Original Contributions

Smoking and the Platelet Fibrinogen Receptor Glycoprotein IIb/IIIA PlA1/A2 Polymorphism Interact in the Risk of Lacunar Stroke and Midterm Survival

Niku K.J. Oksala, MD, PhD; Maarit Heikkinen, MD, PhD; Jussi Mikkelsson, MD, PhD; Tarja Pohjasvaara, MD, PhD; Markku Kaste, MD, PhD; Timo Erkinjuntti, MD, PhD Pekka J. Karhunen, MD, PhD

From the Division of Vascular Surgery, Department of Surgery (N.K.J.O., M.H.), and the Heart Centre (J.M.), Tampere University Hospital, Tampere; the Department of Neurology (T.P., M.K., T.E.), Helsinki University Central Hospital, Helsinki; and the School of Medicine, Forensic Medicine, University of Tampere, and Research Unit of the Centre Laboratory (N.K.J.O., P.J.K.), Tampere University Hospital, Tampere, Finland.

Correspondence to Pekka J. Karhunen, MD, PhD, Department of Forensic Medicine, Medical School, University of Tampere, FI-33014 Tampere, Finland. E-mail pekka.karhunen{at}uta.fi

Background and Purpose— Smoking, increased fibrinogen levels, and platelet activation are related to the risk of ischemic stroke. The platelet fibrinogen receptor glycoprotein (Gp) IIb/IIIa PlA1/A2 polymorphism affects the binding of platelets to fibrinogen and is suggested to interact with smoking.

Methods— We explored the association of smoking and the PlA1/A2 polymorphism with ischemic stroke and survival in the Stroke Aging Memory cohort, comprising 486 consecutive patients (55 to 85 years old) who were analyzed 3 months after an ischemic stroke and followed up for 15 months. Stroke subtype determined by magnetic resonance imaging and GpIIb/IIIa PlA1/A2 genotype data were available for 272 patients.

Results— In multivariate analysis, smoking was the only factor related to the risk of lacunar infarcts (odds ratio [OR]=1.87, 95% CI=1.05 to 3.31; P=0.033), and it was also a predictor of death (n=24, 8.8%) at 15 months (OR=5.13, 95% CI=1.61 to 16.36; P=0.006), along with age (OR=1.10, 95% CI=1.01 to 1.19; P=0.008). The GpIIb/IIIa PlA1/A2 polymorphism alone showed no association with stroke subtype or survival. However, there was a smoking-by-genotype association with the risk of lacunar infarcts (OR=2.10, 95% CI=0.90 to 4.89; P=0.087) and with survival (OR=2.78, 95% CI=0.89 to 8.61; P=0.077). Among younger (55 to 69 years) stroke patients, smokers carrying the PlA2 allele were at a higher (OR=5.81, 95% CI=1.26 to 26.80; P=0.024) risk of lacunar infarcts than noncarrier smokers (OR=3.12, 95% CI=1.06 to 9.24; P=0.039). The effect of PlA2 and smoking combined on survival was also stronger (OR=8.86, 95% CI=1.68 to 46.55; P=0.010) than the effect of smoking alone (OR=5.06, 95% CI=1.20 to 21.35; P=0.027).

Conclusions— Our results indicate that prothrombotic genetic factors may interact with smoking by modifying the stroke phenotype and affecting midterm survival.


Key Words: polymorphisms • smoking • stroke • survival




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
N K J Oksala, H Jokinen, S Melkas, A Oksala, T Pohjasvaara, M Hietanen, R Vataja, M Kaste, P J Karhunen, and T Erkinjuntti
Cognitive impairment predicts poststroke death in long-term follow-up
J. Neurol. Neurosurg. Psychiatry, November 1, 2009; 80(11): 1230 - 1235.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Melkas, N K J Oksala, H Jokinen, T Pohjasvaara, R Vataja, A Oksala, M Kaste, P J Karhunen, and T Erkinjuntti
Poststroke dementia predicts poor survival in long-term follow-up: influence of prestroke cognitive decline and previous stroke
J. Neurol. Neurosurg. Psychiatry, August 1, 2009; 80(8): 865 - 870.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
N K J Oksala, A Oksala, T Pohjasvaara, R Vataja, M Kaste, P J Karhunen, and T Erkinjuntti
Age related white matter changes predict stroke death in long term follow-up
J. Neurol. Neurosurg. Psychiatry, July 1, 2009; 80(7): 762 - 766.
[Abstract] [Full Text] [PDF]